Innovation in hematology. Perspectives: CML 2016

Autor Hehlmann, Rüdiger
Vydáno v Haematologica (2016)

Research in the heart of hematology: chronic myeloid leukemia 2017

Autor Hehlmann, Rüdiger
Vydáno v Haematologica (2017)

Chronic Myeloid Leukemia in 2020

Autor Hehlmann, Rüdiger
Vydáno v Hemasphere (2020)

The New ELN Recommendations for Treating CML

Autor Hehlmann, Rüdiger
Vydáno v J Clin Med (2020)

Genomic Instability in Context of the Chromosomal Theory

Autor Fabarius, Alice, Duesberg, Peter, Giehl, Michelle, Seifarth, Wolfgang, Hochhaus, Andreas, Hehlmann, Rüdiger
Vydáno v Cell Oncol (2008)

Human Endogenous Retrovirus Expression Profiles in Samples from Brains of Patients with Schizophrenia and Bipolar Disorders

Autor Frank, Oliver, Giehl, Michelle, Zheng, Chun, Hehlmann, Rüdiger, Leib-Mösch, Christine, Seifarth, Wolfgang
Vydáno 2005

Rolf Neth (October 6, 1926 to March 17, 2020)

Autor Hehlmann, Rüdiger, Gallo, Robert, Hoelzer, Dieter, Welte, Karl, Gale, Robert Peter, Zander, Axel
Vydáno v Leukemia (2020)

Adhesion to fibronectin stimulates proliferation of wild-type and bcr/abl-transfected murine hematopoietic cells

Autor Krämer, Alwin, Hörner, Susanne, Willer, Andreas, Fruehauf, Stefan, Hochhaus, Andreas, Hallek, Michael, Hehlmann, Rüdiger
Vydáno 1999

Specific Detection of Aspergillus Species in Blood and Bronchoalveolar Lavage Samples of Immunocompromised Patients by Two-Step PCR

Autor Skladny, Heyko, Buchheidt, Dieter, Baust, Corinna, Krieg-Schneider, Frank, Seifarth, Wolfgang, Leib-Mösch, Christine, Hehlmann, Rüdiger
Vydáno 1999

Comprehensive Analysis of Human Endogenous Retrovirus Transcriptional Activity in Human Tissues with a Retrovirus-Specific Microarray

Autor Seifarth, Wolfgang, Frank, Oliver, Zeilfelder, Udo, Spiess, Birgit, Greenwood, Alex D., Hehlmann, Rüdiger, Leib-Mösch, Christine
Vydáno 2005

Variable Transcriptional Activity of Endogenous Retroviruses in Human Breast Cancer

Autor Frank, Oliver, Verbeke, Caroline, Schwarz, Norbert, Mayer, Jens, Fabarius, Alice, Hehlmann, Rüdiger, Leib-Mösch, Christine, Seifarth, Wolfgang
Vydáno 2008

DNA Microarray-Based Detection and Identification of Fungal Pathogens in Clinical Samples from Neutropenic Patients

Autor Spiess, Birgit, Seifarth, Wolfgang, Hummel, Margit, Frank, Oliver, Fabarius, Alice, Zheng, Chun, Mörz, Handan, Hehlmann, Rüdiger, Buchheidt, Dieter
Vydáno 2007

Development of a LightCycler PCR Assay for Detection and Quantification of Aspergillus fumigatus DNA in Clinical Samples from Neutropenic Patients

Autor Spiess, Birgit, Buchheidt, Dieter, Baust, Corinna, Skladny, Heyko, Seifarth, Wolfgang, Zeilfelder, Udo, Leib-Mösch, Christine, Mörz, Handan, Hehlmann, Rüdiger
Vydáno 2003

Proviral Structure, Chromosomal Location, and Expression of HERV-K-T47D, a Novel Human Endogenous Retrovirus Derived from T47D Particles

Autor Seifarth, Wolfgang, Baust, Corinna, Murr, Andreas, Skladny, Heyko, Krieg-Schneider, Frank, Blusch, Jürgen, Werner, Thomas, Hehlmann, Rüdiger, Leib-Mösch, Christine
Vydáno 1998

A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon α

Autor Kreil, Sebastian, Waghorn, Katherine, Ernst, Thomas, Chase, Andrew, White, Helen, Hehlmann, Rüdiger, Reiter, Andreas, Hochhaus, Andreas, Cross, Nicholas C.P.
Vydáno 2010

Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy

Autor Hanfstein, Benjamin, Müller, Martin C., Kreil, Sebastian, Ernst, Thomas, Schenk, Thomas, Lorentz, Christian, Schwindel, Uwe, Leitner, Armin, Hehlmann, Rüdiger, Hochhaus, Andreas
Vydáno 2011

Treatment patterns and clinical outcomes of tyrosine kinase inhibitors in chronic‐phase CML in clinical practice: 3‐year European SIMPLICITY data

Autor Gambacorti‐Passerini, Carlo, Chen, Clara, Davis, Catherine, Sen, Ginny P., Guyan, Christy, Hehlmann, Rüdiger, Michallet, Mauricette, Paquette, Ronald, Goldberg, Stuart L.
Vydáno v Eur J Haematol (2020)

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States

Autor Padula, William V., Larson, Richard A., Dusetzina, Stacie B., Apperley, Jane F., Hehlmann, Rudiger, Baccarani, Michele, Eigendorff, Ekkehard, Guilhot, Joelle, Guilhot, Francois, Hehlmann, Rudiger, Mahon, Francois-Xavier, Martinelli, Giovanni, Mayer, Jiri, Müller, Martin C., Niederwieser, Dietger, Saussele, Susanne, Schiffer, Charles A., Silver, Richard T., Simonsson, Bengt, Conti, Rena M.
Vydáno v J Natl Cancer Inst (2016)

Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy

Autor Haaß, Wiltrud, Kleiner, Helga, Weiß, Christel, Haferlach, Claudia, Schlegelberger, Brigitte, Müller, Martin C., Hehlmann, Rüdiger, Hofmann, Wolf-Karsten, Fabarius, Alice, Seifarth, Wolfgang
Vydáno v PLoS One (2015)

Contemporary insights into the pathogenesis and treatment of chronic myeloproliferative neoplasms

Autor Mughal, Tariq I., Abdel-Wahab, Omar, Rampal, Raajit, Mesa, Ruben, Koschmieder, Steffen, Levine, Ross, Hehlmann, Rüdiger, Saglio, Giuseppe, Barbui, Tiziano, Van Etten, Richard A.
Vydáno v Leuk Lymphoma (2016)